Global competition means that firms are under pressure to systematically develop the
efficiency of their manufacturing processes. However, little has been said in the international …

The role of the public sciences in supporting the growth of new industries with radically
innovative technologies has varied between countries that encourage different levels of …

In this paper we present comparative evidence from OECD countries concerning the impact
of labour market institutions and regulations on technological specialization. The interplay …

It is proposed that developments in the commercialization of science and technology in" new
economy" sectors such as telecommunications, information technology and biotechnology …

This paper provides a critical review of UK government proposals to develop venture capital
funds in the English regions to address the'equity gap'. It argues that there is currently an …

Given what institutional scholars have described as an inhospitable institutional climate for
entrepreneurial business, why has the German biotechnology industry suddenly taken off …

Today, US biotechnology firms dominate the growing therapeutics and diagnostics sectors
despite most of the key discoveries being made by European, and especially UK scientists …

The biotechnology industry is a striking example of the disconnect between the location of
knowledge creation and its commercial development. I argue that national technological …

This paper analyzes how governance structures impact the innovation capabilities of
leading German and UK firms in the pharmaceutical industry. Our main objective is to show …

Institutional systems exert important influences on firms' development of innovative
capabilities. This article examines studies of firms' innovative competencies within the …